Michel Marre
#142,413
Most Influential Person Now
Researcher
Michel Marre's AcademicInfluence.com Rankings
Michel Marrecomputer-science Degrees
Computer Science
#6922
World Rank
#7289
Historical Rank
Data Mining
#162
World Rank
#162
Historical Rank
Algorithms
#254
World Rank
#257
Historical Rank
Machine Learning
#2398
World Rank
#2428
Historical Rank
Download Badge
Computer Science
Michel Marre's Degrees
- PhD Computer Science Université Paris Cité
Similar Degrees You Can Earn
Why Is Michel Marre Influential?
(Suggest an Edit or Addition)Michel Marre's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. (2008) (5018)
- Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index (2010) (2011)
- Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis (2010) (1801)
- Variation in FTO contributes to childhood obesity and severe adult obesity (2007) (1529)
- Severe hypoglycemia and risks of vascular events and death. (2010) (1317)
- Association analyses of 249,796 individuals reveal eighteen new loci associated with body mass index (2010) (1179)
- Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution (2010) (897)
- Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. (2009) (850)
- Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU) (2009) (787)
- Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations (2009) (653)
- A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk (2009) (574)
- Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. (2014) (503)
- Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia (2009) (452)
- 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial (2017) (406)
- Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. (1988) (400)
- Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial (2012) (369)
- Metformin use and mortality among patients with diabetes and atherothrombosis. (2010) (355)
- Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. (1997) (341)
- Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes (2012) (333)
- Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes (2014) (322)
- Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. (2004) (315)
- Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds (2012) (297)
- Common nonsynonymous variants in PCSK1 confer risk of obesity (2008) (288)
- Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study) (2004) (285)
- Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept (2011) (269)
- Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes (2009) (265)
- Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. (2013) (264)
- Lowering blood pressure reduces renal events in type 2 diabetes. (2009) (251)
- New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes (2012) (250)
- ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD – Summary (2014) (245)
- Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. (1987) (243)
- A Polymorphism Within the G6PC2 Gene Is Associated with Fasting Plasma Glucose Levels (2008) (241)
- Relationships Between Angiotensin I Converting Enzyme Gene Polymorphism, Plasma Levels, and Diabetic Retinal and Renal Complications (1994) (235)
- Low copy number of the salivary amylase gene predisposes to obesity (2014) (224)
- Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. (1994) (214)
- Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin (2013) (203)
- Genetic evidence of assortative mating in humans (2017) (199)
- Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. (2004) (198)
- Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON (2016) (185)
- Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by EstablishedBasal Insulin A 24-week, randomized, placebo-controlled comparison (GetGoal-L) (2013) (178)
- The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation (2015) (178)
- Dairy Consumption and the Incidence of Hyperglycemia and the Metabolic Syndrome (2011) (177)
- Combined effects of MC4R and FTO common genetic variants on obesity in European general populations (2009) (176)
- The Common P446L Polymorphism in GCKR Inversely Modulates Fasting Glucose and Triglyceride Levels and Reduces Type 2 Diabetes Risk in the DESIR Prospective General French Population (2008) (176)
- Whole-Exome Sequencing and High Throughput Genotyping Identified KCNJ11 as the Thirteenth MODY Gene (2012) (168)
- Blood Microbiota Dysbiosis Is Associated with the Onset of Cardiovascular Events in a Large General Population: The D.E.S.I.R. Study (2013) (166)
- Impact of Common Type 2 Diabetes Risk Polymorphisms in the DESIR Prospective Study (2008) (164)
- Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes Mellitus (2016) (161)
- Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1-3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10). (2020) (156)
- Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse (2001) (153)
- Genome-wide physical activity interactions in adiposity ― A meta-analysis of 200,452 adults (2017) (153)
- Post Genome-Wide Association Studies of Novel Genes Associated with Type 2 Diabetes Show Gene-Gene Interaction and High Predictive Value (2008) (148)
- Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: The NESTOR* study (2004) (146)
- Relation of the Mediterranean diet with the incidence of gestational diabetes (2014) (146)
- Efficacy and Safety of Sitagliptin Versus Glipizide in Patients With Type 2 Diabetes and Moderate-to-Severe Chronic Renal Insufficiency (2013) (145)
- Ferritin and Transferrin Are Associated With Metabolic Syndrome Abnormalities and Their Change Over Time in a General Population (2007) (144)
- Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation (2001) (140)
- Ferritin and Transferrin Are Both Predictive of the Onset of Hyperglycemia in Men and Women Over 3 Years (2006) (138)
- Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system. (2003) (137)
- Circulating Inflammatory Markers and the Risk of Vascular Complications and Mortality in People With Type 2 Diabetes and Cardiovascular Disease or Risk Factors: The ADVANCE Study (2014) (137)
- G-allele of Intronic rs10830963 in MTNR1B Confers Increased Risk of Impaired Fasting Glycemia and Type 2 Diabetes Through an Impaired Glucose-Stimulated Insulin Release (2009) (136)
- Low Water Intake and Risk for New-Onset Hyperglycemia (2011) (135)
- The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies (2008) (132)
- Comparison of waist-to-hip ratio and other obesity indices as predictors of cardiovascular disease risk in people with type-2 diabetes: a prospective cohort study from ADVANCE (2011) (131)
- Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes (2012) (129)
- Contemporary model for cardiovascular risk prediction in people with type 2 diabetes (2011) (123)
- Leveraging Cross-Species Transcription Factor Binding Site Patterns: From Diabetes Risk Loci to Disease Mechanisms (2014) (120)
- Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study. (2001) (120)
- Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study (2006) (115)
- Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney disease. (2014) (112)
- TCF7L2 Variation Predicts Hyperglycemia Incidence in a French General Population (2006) (109)
- Prediction of kidney-related outcomes in patients with type 2 diabetes. (2012) (106)
- Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects (2005) (106)
- Common genetic variation near MC4R is associated with eating behaviour patterns in European populations (2009) (105)
- A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes (2018) (105)
- Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution (2011) (104)
- Laser immunonephelometry for routine quantification of urinary albumin excretion. (1987) (100)
- Lower extremity arterial disease in patients with diabetes: a contemporary narrative review (2018) (99)
- Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen. (2019) (98)
- Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes. (2004) (97)
- R125W coding variant in TBC1D1 confers risk for familial obesity and contributes to linkage on chromosome 4p14 in the French population. (2008) (94)
- Effects of TCF7L2 Polymorphisms on Obesity in European Populations (2008) (93)
- Association between large detectable clonal mosaicism and type 2 diabetes with vascular complications (2013) (92)
- Hyperglycemia-induced defects in angiogenesis in the chicken chorioallantoic membrane model. (2004) (92)
- Improved glycaemic control with metformin–glibenclamide combined tablet therapy (Glucovance®) in Type 2 diabetic patients inadequately controlled on metformin (2002) (89)
- Analysis of 14 Candidate Genes for Diabetic Nephropathy on Chromosome 3q in European Populations (2006) (88)
- Comment on "A Common Genetic Variant Is Associated with Adult and Childhood Obesity" (2007) (86)
- Short Report: Treatment Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal–bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN® Basal–Bolus Type 1): 2-year results of a randomized clinical trial (2013) (86)
- Glycaemic control in type 1 diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study. (2001) (84)
- Association of Sirtuin 1 (SIRT1) Gene SNPs and Transcript Expression Levels With Severe Obesity (2012) (82)
- Analysis of novel risk loci for type 2 diabetes in a general French population: the D.E.S.I.R. study (2008) (82)
- Evaluation of a new non‐mydriatic digital camera for detection of diabetic retinopathy (2003) (82)
- Hypertension and diabetes mellitus. (1993) (81)
- Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes. (1993) (81)
- Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes (2016) (78)
- Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies (2018) (78)
- Plasma Copeptin and Renal Outcomes in Patients With Type 2 Diabetes and Albuminuria (2013) (77)
- The G-allele of intronic rs 10830963 in MTNR 1 B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release : studies involving 19 , 605 Europeans (2009) (77)
- Telematic Transmission of Computerized Blood Glucose Profiles for IDDM Patients (1991) (75)
- Association between angiotensin-converting enzyme gene polymorphisms and diabetic nephropathy: case-control, haplotype, and family-based study in three European populations. (2007) (74)
- Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study (2016) (73)
- Nateglinide improves glycaemic control when added to metformin monotherapy: results of a randomized trial with type 2 diabetes patients (2002) (72)
- A Rare Variant in the Visfatin Gene (NAMPT/PBEF1) Is Associated With Protection From Obesity (2009) (70)
- Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes (2017) (69)
- Proposed criteria for the diagnosis of diabetes: evidence from a French epidemiological study (D.E.S.I.R.). (1997) (69)
- The influence of physical activity on vascular complications and mortality in patients with type 2 diabetes mellitus (2013) (65)
- Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the Genesis France-Belgium Study. (2004) (65)
- Factors Associated With Weight Gain in People With Type 2 Diabetes Starting on Insulin (2014) (64)
- Plasma Copeptin, AVP Gene Variants, and Incidence of Type 2 Diabetes in a Cohort From the Community. (2016) (64)
- Kallikrein protects against microalbuminuria in experimental type I diabetes. (2009) (63)
- Relationship Between Levels of Advanced Glycation End Products and Their Soluble Receptor and Adverse Outcomes in Adults With Type 2 Diabetes (2015) (61)
- Cause-specific mortality in diabetes: recent changes in trend mortality (2012) (60)
- A Fully Automated Web-Based Program Improves Lifestyle Habits and HbA1c in Patients With Type 2 Diabetes and Abdominal Obesity: Randomized Trial of Patient E-Coaching Nutritional Support (The ANODE Study) (2017) (59)
- Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19 (2020) (59)
- Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial (2018) (59)
- Polymorphisms of the receptor of advanced glycation endproducts (RAGE) and the development of nephropathy in type 1 diabetic patients. (2005) (57)
- Contribution of 24 obesity-associated genetic variants to insulin resistance, pancreatic beta-cell function and type 2 diabetes risk in the French population (2013) (57)
- Analysis of common PTPN1 gene variants in type 2 diabetes, obesity and associated phenotypes in the French population (2006) (57)
- ENPP1 K121Q polymorphism and obesity, hyperglycaemia and type 2 diabetes in the prospective DESIR Study (2007) (56)
- Fetal Exposure to Maternal Type 1 Diabetes Is Associated With Renal Dysfunction at Adult Age (2010) (55)
- Effects of Enalapril in Insulin-Dependent Diabetic Subjects With Mild to Moderate Uncomplicated Hypertension (1987) (54)
- Screening for diabetic retinopathy: the first telemedical approach in a primary care setting in France. (2004) (53)
- ABCA1 Single Nucleotide Polymorphisms on High‐Density Lipoprotein‐Cholesterol and Overweight: the D.E.S.I.R. Study (2006) (53)
- Dietary fat intake and polymorphisms at the PPARG locus modulate BMI and type 2 diabetes risk in the D.E.S.I.R. prospective study (2012) (53)
- Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies (2017) (52)
- Before oral agents fail: the case for starting insulin early (2002) (52)
- G/T Substitution in Intron 1 of the UNC13B Gene Is Associated With Increased Risk of Nephropathy in Patients With Type 1 Diabetes (2008) (52)
- Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: A perspective on glucose‐lowering interventions (2018) (51)
- Prognostic Value of the Insertion/Deletion Polymorphism of the ACE Gene in Type 2 Diabetic Subjects: Results From the Non-Insulin-Dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEP (2008) (51)
- Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial. (2014) (51)
- Selective Kinin Receptor Agonists as Cardioprotective Agents in Myocardial Ischemia and Diabetes (2013) (51)
- Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 Diabetes (2016) (51)
- The loss-of-function PCSK9 p.R46L genetic variant does not alter glucose homeostasis (2015) (51)
- Cardiovascular risk in relation to body mass index and use of evidence-based preventive medications in patients with or at risk of atherothrombosis. (2015) (50)
- Prognostic Value of the Insertion/ Deletion polymorphism of Angiotensin I Converting Enzyme gene in type 2 diabetic subjects: results from the DIABHYCAR, DIAB2NEPHROGENE & SURDIAGENE studies. (2008) (49)
- The Common −866G>A Variant in the Promoter of UCP2 Is Associated With Decreased Risk of Coronary Artery Disease in Type 2 Diabetic Men (2008) (49)
- Allelic variations of the vitamin D receptor (VDR) gene are associated with increased risk of coronary artery disease in type 2 diabetics: the DIABHYCAR prospective study. (2013) (48)
- Dairy Products and the Metabolic Syndrome in a Prospective Study, DESIR (2011) (48)
- Association between high von Willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes (2000) (47)
- Microalbuminuria as a predictor of a drop in glomerular filtration rate in subjects with non-insulin-dependent diabetes mellitus and hypertension. (1997) (45)
- What Is the Contribution of Two Genetic Variants Regulating VEGF Levels to Type 2 Diabetes Risk and to Microvascular Complications? (2013) (45)
- SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetes (2014) (45)
- Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetes (2015) (44)
- Diuretic and natriuretic effects of nifedipine on isolated perfused rat kidneys. (1982) (44)
- Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes (2015) (44)
- Relationships between common polymorphisms of adenosine triphosphate-binding cassette transporter A1 and high-density lipoprotein cholesterol and coronary heart disease in a population with type 2 diabetes mellitus. (2009) (43)
- Efficacy of diuretics and beta-blockers in diabetic hypertensive patients. Results from a meta-analysis. The INDANA Steering Committee. (2000) (43)
- COMPARISON OF THE LONG-TERM EFFECTS OF LIRAGLUTIDE AND GLIMEPIRIDE MONOTHERAPY ON BONE MINERAL DENSITY IN PATIENTS WITH TYPE 2 DIABETES. (2016) (43)
- Allelic variations in superoxide dismutase-1 (SOD1) gene and renal and cardiovascular morbidity and mortality in type 2 diabetic subjects. (2012) (43)
- Relationships between abdominal body fat distribution and cardiovascular risk factors: an explanation for women’s healthier cardiovascular risk profile. The D.E.S.I.R. Study (1999) (42)
- Type 2 diabetes-related genetic risk scores associated with variations in fasting plasma glucose and development of impaired glucose homeostasis in the prospective DESIR study (2014) (42)
- Relationship between salivary/pancreatic amylase and body mass index: a systems biology approach (2017) (42)
- Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON (2017) (41)
- Evaluation of a screening program for diabetic retinopathy in a primary care setting Dodia (Dépistage ophtalmologique du diabète) study. (2005) (41)
- Lessons learned from biosimilar epoetins and insulins (2010) (41)
- Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control (2018) (41)
- Regulation of kallikrein and renin release by the isolated perfused rat kidney. (1983) (41)
- Plasma Copeptin and Decline in Renal Function in a Cohort from the Community: The Prospective D.E.S.I.R. Study (2015) (40)
- Allelic variations in superoxide dismutase-1 (SOD1) gene are associated with increased risk of diabetic nephropathy in type 1 diabetic subjects. (2011) (40)
- Is Microalbuminuria an Integrated Risk Marker for Cardiovascular Disease and Insulin Resistance in Both Men and Women? (2001) (40)
- The Non–Insulin-Dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) Study: Design, Organization, and Patient Recruitment (2000) (39)
- The efficacy of lowering glycated haemoglobin with a gliclazide modified release-based intensive glucose lowering regimen in the ADVANCE trial. (2010) (39)
- The lactase persistence genotype is associated with body mass index and dairy consumption in the D.E.S.I.R. study. (2013) (39)
- The place of gliclazide MR in the evolving type 2 diabetes landscape: A comparison with other sulfonylureas and newer oral antihyperglycemic agents. (2018) (39)
- Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study (2008) (39)
- Adding Liraglutide to Oral Antidiabetic Drug Monotherapy: Efficacy and Weight Benefits (2009) (39)
- European rational approach for the genetics of diabetic complications--EURAGEDIC: patient populations and strategy. (2007) (38)
- The brain-islet axis: the nervous control of the endocrine pancreas. (1982) (38)
- Small Doses of Ramipril to Reduce Microalbuminuria in Diabetic Patients with Incipient Nephropathy Independently of Blood Pressure Changes (1991) (38)
- Renal changes on hyperglycemia and angiotensin-converting enzyme in type 1 diabetes. (1999) (38)
- Benefits of Ophdiat, a telemedical network to screen for diabetic retinopathy: a retrospective study in five reference hospital centres. (2009) (38)
- Loss-of-function mutations in MRAP2 are pathogenic in hyperphagic obesity with hyperglycemia and hypertension (2019) (38)
- Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial (2018) (38)
- Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in type 2 diabetes. (2010) (37)
- Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus: The ADVANCE Trial (2019) (37)
- Lack of relationship in long‐term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein ε, lipoprotein lipase and cholesteryl ester transfer protein (2000) (36)
- Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular risk (2017) (36)
- Strong association of common variants in the CDKN2A/CDKN2B region with type 2 diabetes in French Europids (2008) (36)
- Glomerular hyperfiltration in type I, type II, and secondary diabetes. (1992) (35)
- Genetic Variant in HK1 Is Associated With a Proanemic State and A1C but Not Other Glycemic Control–Related Traits (2009) (35)
- Prognostic Value of the Insertion/Deletion Polymorphism of the ACE Gene in Type 2 Diabetic Subjects (2008) (35)
- Associations between body mass index and the risk of renal events in patients with type 2 diabetes (2018) (34)
- Evaluation of the Association of IGF2BP2 Variants With Type 2 Diabetes in French Caucasians (2008) (34)
- Dynamic Changes in Renal Function Are Associated With Major Cardiovascular Events in Patients With Type 2 Diabetes (2016) (33)
- Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes (2018) (33)
- Reassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetes (2013) (33)
- Genetic and Functional Assessment of the Role of the rs13431652-A and rs573225-A Alleles in the G6PC2 Promoter That Are Strongly Associated With Elevated Fasting Glucose Levels (2010) (33)
- Factors influencing initial choice of insulin therapy in a large international non-interventional study of people with type 2 diabetes (2012) (33)
- Glucose control in critically ill patients. (2009) (32)
- Manganese Superoxide Dismutase (SOD2) Polymorphisms, Plasma Advanced Oxidation Protein Products (AOPP) Concentration and Risk of Kidney Complications in Subjects with Type 1 Diabetes (2014) (32)
- A novel device for measuring arterial stiffness using finger-toe pulse wave velocity: Validation study of the pOpmètre®. (2015) (32)
- Association between alcohol consumption and diabetic retinopathy and visual acuity—the AdRem Study (2010) (31)
- Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 Diabetes (2016) (31)
- Genetics and the prediction of complications in type 1 diabetes. (1999) (31)
- Novel risk genes identified in a genome-wide association study for coronary artery disease in patients with type 1 diabetes (2018) (31)
- Value of ambulatory blood pressure monitoring in type I (insulin-dependent) diabetic patients with incipient diabetic nephropathy. (1994) (30)
- Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy (2018) (30)
- Lower limb events in individuals with type 2 diabetes: evidence for an increased risk associated with diuretic use (2019) (30)
- The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study (2019) (30)
- A composite risk assessment model to screen for gestational diabetes mellitus among Mediterranean women (2013) (30)
- Do Cardiac Biomarkers NT-proBNP and hsTnT Predict Microvascular Events in Patients With Type 2 Diabetes? Results From the ADVANCE Trial (2014) (29)
- Genetic Association Analyses Highlight IL6, ALPL, and NAV1 As 3 New Susceptibility Genes Underlying Calcific Aortic Valve Stenosis. (2019) (29)
- Association of vitronectin and plasminogen activator inhibitor-1 levels with the risk of metabolic syndrome and type 2 diabetes mellitus (2011) (29)
- Glutathione peroxidase-1 gene (GPX1) variants, oxidative stress and risk of kidney complications in people with type 1 diabetes. (2016) (29)
- Plasma concentrations of 8-hydroxy-2′-deoxyguanosine and risk of kidney disease and death in individuals with type 1 diabetes (2018) (27)
- Decreased insulin secretion and increased risk of type 2 diabetes associated with allelic variations of the WFS1 gene: the Data from Epidemiological Study on the Insulin Resistance Syndrome (DESIR) prospective study (2011) (27)
- Contribution of the low-frequency, loss-of-function p.R270H mutation in FFAR4 (GPR120) to increased fasting plasma glucose levels (2015) (26)
- Interest of Clinitek Microalbumin in screening for microalbuminuria: results of a multicentre study in 302 diabetic patients. (2001) (26)
- Pathogenic variants in actionable MODY genes are associated with type 2 diabetes (2020) (26)
- The Amino Acid-Induced Secretion of Glucagon (1983) (26)
- Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single‐tablet metformin–glibenclamide therapy (Glucovance®) in type 2 diabetes (2003) (25)
- 40th EASD Annual Meeting of the European Association for the Study of Diabetes (2004) (25)
- Plasma copeptin and chronic kidney disease risk in 3 European cohorts from the general population. (2018) (25)
- Cross-sectional study of care, socio-economic status and complications in young French patients with type 1 diabetes mellitus. (2005) (25)
- PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study (2017) (25)
- Angiotensin‐I‐converting enzyme insertion/deletion polymorphism and high urinary albumin concentration in French Type 2 diabetes patients (2003) (25)
- A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus (2010) (25)
- Relationship between cardiac microvascular dysfunction measured with 82Rubidium-PET and albuminuria in patients with diabetes mellitus (2018) (24)
- Modulation of the renal response to ACE inhibition by ACE insertion/deletion polymorphism during hyperglycemia in normotensive, normoalbuminuric type 1 diabetic patients. (2005) (24)
- Efficacy of indapamide SR compared with enalapril in elderly hypertensive patients with type 2 diabetes. (2007) (23)
- Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain: 52-week data from the PREDICTIVE study in a cohort of French patients with type 1 or type 2 diabetes. (2009) (23)
- The expression of genes in top obesity-associated loci is enriched in insula and substantia nigra brain regions involved in addiction and reward (2019) (23)
- Kinins as therapeutic agents in cardiovascular and renal diseases. (2011) (23)
- Genetic variability at the six transmembrane protein of prostate 2 locus and the metabolic syndrome: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study. (2010) (23)
- GLP-1 receptor agonists today. (2011) (23)
- Kidney Dysfunction in Adult Offspring Exposed In Utero to Type 1 Diabetes Is Associated with Alterations in Genome-Wide DNA Methylation (2015) (23)
- Association between high von willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes. The GENEDIAB Study Group and the DESIR Study Group. (2000) (22)
- Impact of Natriuretic Peptide Clearance Receptor (NPR3) Gene Variants on Blood Pressure in Type 2 Diabetes (2011) (22)
- The impact of level of education on vascular events and mortality in patients with type 2 diabetes mellitus: Results from the ADVANCE study. (2017) (22)
- Adiponectin Multimers and ADIPOQ T45G in Coronary Artery Disease in Caribbean Type 2 Diabetic Subjects of African Descent (2010) (22)
- Superior weight loss with once-weekly semaglutide versus other glucagon-like peptide-1 receptor agonists is independent of gastrointestinal adverse events (2020) (22)
- Relationship between glomerular hyperfiltration and ACE insertion/deletion polymorphism in type 1 diabetic children and adolescents. (1999) (21)
- Antihypertensive efficacy and acceptability of perindopril in elderly hypertensive patients. (1993) (21)
- Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settings. (2019) (21)
- Associations of the -344 T>C and the 3097 G>A polymorphisms of CYP11B2 gene with hypertension, type 2 diabetes, and metabolic syndrome in a French population. (2010) (21)
- Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP‐1RA treatment: A subgroup analysis from the FIDELIO‐DKD trial (2021) (21)
- Sex-specific associations of variants in regulatory regions of NADPH oxidase-2 (CYBB) and glutathione peroxidase 4 (GPX4) genes with kidney disease in type 1 diabetes (2013) (21)
- Relationship Between Plasma 8‐OH‐Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE Trial (2018) (21)
- Determinants of elevated urinary albumin in the 4,937 type 2 diabetic subjects recruited for the DIABHYCAR Study in Western Europe and North Africa. (2000) (21)
- Investigation of the human ANP gene in type 1 diabetic nephropathy: case-control and follow-up studies. (2004) (21)
- Parental history of type 2 diabetes, TCF7L2 variant and lower insulin secretion are associated with incident hypertension. Data from the DESIR and RISC cohorts (2013) (20)
- Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: Results from the CORONADO study (2021) (20)
- NMR-based prediction of cardiovascular risk in diabetes (2007) (20)
- Development of a Phenotypic Method for Detection of Fecal Carriage of OXA-48-Producing Enterobacteriaceae after Incidental Detection from Clinical Specimen (2011) (20)
- The non-insulin-dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and ramipril (DIABHYCAR) study: design, organization, and patient recruitment. DIABHYCAR Study Group. (2000) (20)
- Differential β-cell response to glucose, glucagon, and arginine during progression to type I (insulin-dependent) diabetes mellitus (1996) (20)
- Predictive value of testing random urine sample to detect microalbuminuria in diabetic subjects during outpatient visit. (1992) (20)
- Interaction between diabetes and a high ankle–brachial index on mortality risk (2015) (20)
- Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein. Genétique de la Nephropathie Diabétique Study Group. Données Epidémiologiques sur le Syndrome d'Insulino-Rés (2000) (19)
- Necrobiosis lipoidica: treatment by hyperbaric oxygen and local corticosteroids. (1998) (19)
- Ambulatory blood pressure and urinary albumin excretion in diabetic (non-insulin-dependent and insulin-dependent) hypertensive patients: relationships at baseline and after treatment by the angiotensin converting enzyme inhibitor trandolapril. (1998) (19)
- Cause-specific mortality in diabetes: recent changes in trend mortality. (2012) (18)
- Impact of statistical models on the prediction of type 2 diabetes using non-targeted metabolomics profiling (2016) (18)
- Lower-extremity amputation as a marker for renal and cardiovascular events and mortality in patients with long standing type 1 diabetes (2016) (18)
- Evaluating the association of common PBX1 variants with type 2 diabetes (2008) (18)
- Microalbuminuria and markers of the atherosclerotic process: the D.E. S.I.R. study. (2001) (18)
- Relationship between fat intake and glomerular filtration rate in normotensive insulin-dependent diabetic patients. (1995) (17)
- [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes]. (2002) (17)
- Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus: The ADVANCE Trial (2019) (17)
- Minor contribution of SMAD7 and KLF10 variants to genetic susceptibility of type 2 diabetes. (2007) (17)
- Evaluating the association of common APOA2 variants with type 2 diabetes (2008) (17)
- Severe Chronic Kidney Disease Is Associated with a Lower Efficiency of Bariatric Surgery (2019) (16)
- Plasma proprotein‐convertase‐subtilisin/kexin type 9 (PCSK9) and cardiovascular events in type 2 diabetes (2018) (16)
- T-cadherin gene variants are associated with type 2 diabetes and the Fatty Liver Index in the French population. (2017) (16)
- Intensification of medication and glycaemic control among patients with type 2 diabetes – the ADVANCE trial (2014) (16)
- Elevated serum angiotensin I converting enzyme activity in type I, insulin-dependent diabetic subjects with persistent microalbuminuria (1992) (16)
- Elevated serum angiotensin I converting enzyme activity in type I insulin-dependent diabetic subjects with persistent microalbuminuria (1992) (16)
- Hereditary factors in the development of diabetic renal disease. (2000) (16)
- Comparative Study of NPH Human Insulin (recombinant DNA) and NPH Bovine Insulin in Diabetic Subjects (1982) (15)
- Paraneoplastic hypoglycemia in a patient with a malignant solitary fibrous tumor (2014) (15)
- Evaluating the Association of FAAH Common Gene Variation with Childhood, Adult Severe Obesity and Type 2 Diabetes in the French Population (2008) (15)
- Corrigendum: Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis (2011) (15)
- The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure–Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial (2021) (15)
- Control of Gastric Glucagon Secretion in the Acutely Pancreatectomized Rat (1979) (15)
- Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes. (2015) (15)
- Survival and rehabilitation after total pancreatectomy. A follow-up of 36 patients. (1985) (15)
- Prevalence of Microalbuminuria in the Diabetic Clinic (1988) (15)
- A polymorphism in the angiotensin II type 1 receptor gene has different effects on the risk of diabetic nephropathy in men and women. (2011) (14)
- Effect of insulin detemir dose frequency on clinical outcomes in patients with diabetes in PREDICTIVE (2009) (14)
- Evaluating the association of common LMNA variants with type 2 diabetes and quantitative metabolic phenotypes in French Europids (2007) (14)
- Low-Frequency Variants in HMGA1 Are Not Associated With Type 2 Diabetes Risk (2012) (14)
- Erratum: ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD (European Heart Journal (2013) 34 (3035-3087) Doi:10.1093/eurheartj/eht108) (2014) (14)
- Acute insulin response to intravenous glucose, glucagon and arginine in some subjects at risk for Type 1 (insulin-dependent) diabetes mellitus (1991) (14)
- The nervous control of rat glucagon secretion in vivo. (1983) (14)
- Catalase activity, allelic variations in the catalase gene and risk of kidney complications in patients with type 1 diabetes (2013) (13)
- The nervous control of rat somatostatin, glucagon and insulin secretions. (1982) (13)
- ENALAPRIL, CAPTOPRIL, AND BLOOD GLUCOSE (1986) (13)
- Transforming growth factor-β1 production is correlated with genetically determined ACE expression in congenic rats: A possible link between ACE genotype and diabetic nephropathy (2004) (13)
- Differential beta-cell response to glucose, glucagon, and arginine during progression to type I (insulin-dependent) diabetes mellitus. (1996) (13)
- Non‐severe hypoglycaemia is associated with weight gain in patients with type 1 diabetes: Results from the Diabetes Control and Complication Trial (2018) (13)
- Analysis of KLF transcription factor family gene variants in type 2 diabetes (2007) (13)
- Functional annotations of diabetes nephropathy susceptibility loci through analysis of genome-wide renal gene expression in rat models of diabetes mellitus (2009) (13)
- New roles for prokineticin 2 in feeding behavior, insulin resistance and type 2 diabetes: Studies in mice and humans (2019) (13)
- Thiazolidinedione use is not associated with worse cardiovascular outcomes: a study in 28,332 high risk patients with diabetes in routine clinical practice: brief title: thiazolidinedione use and mortality. (2013) (13)
- The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE. (2019) (13)
- Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients. (1999) (13)
- La mutation C677T du gène de la 5,10–méthyltétrahydrofolate réductase est associée aux thromboses veineuses idiopathiques (2003) (13)
- ALBUMINURIA AND DIABETIC RETINOPATHY (1985) (12)
- Lifestyle intervention enhances high-density lipoprotein function among patients with metabolic syndrome only at normal low-density lipoprotein cholesterol plasma levels. (2016) (12)
- Plasma Apelin and Risk of Type 2 Diabetes in a Cohort From the Community (2019) (12)
- Use of Fibrates Monotherapy in People with Diabetes and High Cardiovascular Risk in Primary Care: A French Nationwide Cohort Study Based on National Administrative Databases (2015) (12)
- Epidemiology of microalbuminuria in a French population. (1994) (12)
- Novel Susceptibility Locus at 22q11 for Diabetic Nephropathy in Type 1 Diabetes (2011) (12)
- Normal and abnormal day-to-day variability of urinary albumin excretion in control and diabetic subjects. (2000) (11)
- Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study (2018) (11)
- Transforming growth factor-beta 1 production is correlated with genetically determined ACE expression in congenic rats: a possible link between ACE genotype and diabetic nephropathy. (2004) (11)
- 35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
- Prognostic Values of Inflammatory and Redox Status Biomarkers on the Risk of Major Lower-Extremity Artery Disease in Individuals With Type 2 Diabetes (2018) (11)
- Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control (2021) (11)
- Hyperglycaemia in pregnancy in Mediterranean women (2012) (11)
- Smallness for gestational age interacts with high mobility group A2 gene genetic variation to modulate height. (2009) (11)
- Secretory granule neuroendocrine protein 1 (SGNE1) genetic variation and glucose intolerance in severe childhood and adult obesity (2007) (11)
- Impact of morbid obesity on the kidney function of patients with type 2 diabetes. (2015) (10)
- Leukocyte Telomere Length, DNA Oxidation, and Risk of Lower-Extremity Amputation in Patients With Long-standing Type 1 Diabetes (2020) (10)
- Reciprocal Gastropancreatic Modulations for the Release of Somatostatin-like Immunoreactivity, Glucagon, and Insulin in the Rat (1983) (10)
- Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 Diabetes (2019) (10)
- Type B insulin resistance syndrome associated with an immune reconstitution inflammatory syndrome in an HIV-infected woman. (2011) (10)
- [Arterial hypertension and diabetes. Members of the Board of Directors and Scientific Directors of ALFEDIAM]. (1996) (10)
- ABCG8 polymorphisms and renal disease in type 2 diabetic patients. (2015) (10)
- Does PERISCOPE provide a new perspective on diabetic treatment? (2008) (10)
- Reduced nocturnal hypoglycaemia with basal insulin peglispro compared with insulin glargine: pooled analyses of five randomized controlled trials (2016) (10)
- Plasma Adrenomedullin and Allelic Variation in the ADM Gene and Kidney Disease in People With Type 2 Diabetes (2015) (10)
- Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO study (2021) (10)
- Association of common variants in NPPA and NPPB with blood pressure does not translate into kidney damage in a general population study (2010) (9)
- Correction: Genome-wide physical activity interactions in adiposity ― A meta-analysis of 200,452 adults (2017) (9)
- Interaction between GPR120 p.R270H loss-of-function variant and dietary fat intake on incident type 2 diabetes risk in the D.E.S.I.R. study. (2016) (8)
- [Fundus photography for the screening for diabetic retinopathy]. (2002) (8)
- Genome-wide association study of diabetic kidney disease highlights biology involved in renal basement membrane collagen (2018) (8)
- Hyperadiponectinemia is independent of kidney function, diabetes duration, and control in type 1 diabetic patients without microangiopathy. (2011) (8)
- Response of 1,5‐anhydroglucitol level to intensive glucose‐ and blood‐pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial (2019) (8)
- Improved glycemic control with insulin aspart in type-1 diabetic patients using algorith-driven dose optimization (2000) (8)
- The Association of High-Density Lipoprotein Cholesterol with Cancer Incidence in Type II Diabetes: A Case of Reverse Causality? (2013) (8)
- Prevention of diabetic nephropathy with enalapril. (1989) (8)
- Intensive glucose‐lowering and the risk of vascular events and premature death in patients with decreased kidney function: The ADVANCE trial (2019) (8)
- [Value of combined subcutaneous infusion of insulin and metformin in 10 insulin-dependent obese diabetics]. (1987) (8)
- R 125 W coding variant in TBC 1 D 1 confers risk for familial obesity and contributes to linkage on chromosome 4 p 14 in the French population (2008) (8)
- Combined Analysis of Islet Cell Antibodies That Cross-React with Mouse Pancreas, Antibodies to the Mr 64,000 Islet Protein, and Antibodies to Glutamate Decarboxylase in Type I Diabetic Patients (1994) (8)
- Programme « L&Vous » : élaboration d’une charte de bonne utilisation de l’insuline basale chez le patient diabétique de type 2 (2014) (8)
- Sex Difference In the Effect of Fetal Exposure to Maternal Diabetes on Insulin Secretion (2018) (8)
- Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study (2021) (8)
- Microalbuminuria and prevention of renal insufficiency and cardiovascular diseases. (1998) (7)
- Monogenic diabetes characteristics in a transnational multicenter study from Mediterranean countries. (2020) (7)
- Diabetic nephropathy: the ACE hypothesis. (1996) (7)
- A G / T substitution in intron-1 of UNC 13 B gene is associated with increased risk of nephropathy in patients with type 1 diabetes (2008) (7)
- [Larger waist circumference is a predictive factor for the occurrence of microalbuminuria in a non-diabetic population]. (2006) (7)
- Importance of intensive blood pressure control in type 2 diabetes: Mechanisms, treatments and current guidelines (2019) (7)
- Glycosuria amount in response to hyperglycaemia and risk for diabetic kidney disease and related events in Type 1 diabetic patients. (2018) (7)
- Genome-wide physical activity interactions in adiposity ― A meta-analysis of 200,452 adults (2016) (7)
- The evaluation of off-loading using a new removable oRTHOsis in DIABetic foot (ORTHODIAB) randomized controlled trial: study design and rational (2016) (7)
- Tissue kallikrein deficiency, insulin resistance, and diabetes in mouse and man. (2014) (7)
- Clinical Effects of Calcium Antagonists in Hypertensive Diabetics (1990) (7)
- Prévalence de la microalbuminurie chez les diabétiques de Type 2 français suivis par leur médecin généraliste (1995) (6)
- Intensifying glycaemic control with insulin reduces adiponectin and its HMW isoform moderately in type 2, but not in type 1, diabetes. (2011) (6)
- Common variants near BDNF and SH2B1 show nominal evidence of association with snacking behavior in European populations (2013) (6)
- P72 Programme « L & Vous » : élaboration d’une charte de bonne utilisation de l’insuline basale chez le patient diabétique de type 2 (2014) (6)
- Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trial. (2003) (6)
- Insulin regimens and glycemic control in different parts of Europe over 4years after starting insulin in people with type 2 diabetes: Data from the CREDIT non-interventional study. (2017) (6)
- [ESC guidelines on diabetes, pre-diabetes and diseases of the cardiovascular system developed in cooperation with the EASD]. (2013) (6)
- The comparative effects of intensive glucose lowering in diabetes patients aged below or above 65 years: Results from the ADVANCE trial (2020) (6)
- Lack of contribution of two endotelial nitric oxide synthase (eNOS) gene polymorphisms to diabetic nephropathy in type 1 diabetes (1999) (6)
- [Microalbuminuria. Signification and value]. (1993) (6)
- Dissociated effects of nicardipine on vascular tone and insulin secretion. (1986) (5)
- [Evaluation of a screening programme for diabetic retinopathy (DODIA study)]. (2007) (5)
- Use of insulin degludec, a new basal insulin with an ultra-long duration of action, in basal-bolus therapy in type 1 and type 2 diabetes. (2013) (5)
- Programme L&Vous : premiers enseignements de l’Observatoire National de l’Utilisation, en vie réelle, de l’Insuline Basale par les patients diabétiques de Type 2 (2015) (5)
- Nateglinide added to metformin offers safe and effective treatment for type 2 diabetics (2000) (5)
- Polymorphisms of the lamina maturation pathway and their association with the metabolic syndrome: the DESIR prospective study (2010) (5)
- T-cadherin gene variants are associated with nephropathy in subjects with type 1 diabetes. (2017) (5)
- L’éducation thérapeutique du patient (ETP), une pièce maîtresse pour répondre aux nouveaux besoins de lamédecine (2013) (5)
- Hypertension artérielle et diabète (1996) (5)
- [Decrease of nocturnal blood pressure in type II diabetic subjects with microalbuminuria]. (1996) (5)
- [Relation between urinary albumin excretion and retinopathy in insulin-dependent diabetics]. (1986) (5)
- Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes (2016) (5)
- Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy (1996) (5)
- Relationship Between Diabetic Retinopathy Stages and Risk of Major Lower-Extremity Arterial Disease in Patients With Type 2 Diabetes (2020) (5)
- Outpatient measurement of arterial stiffness in patients with type 2 diabetes and obesity (2017) (5)
- Multiple antibody status in type 1 diabetic patients and subjects at various risk with islet-cell antibodies. (1997) (5)
- [Prevalence of microalbuminuria in French type 2 diabetics followed by their general practitioner]. (1995) (5)
- History of lower-limb complications and risk of cancer death in people with type 2 diabetes (2021) (4)
- [Microabluminuria in arterial hypertension. Measurement, variables, interpretation, recommendations]. (2000) (4)
- Intérêt de l'association infusion sous-cutanée d'insuline et metformine chez 10 diabétiques insulino-nécessitants obèses (1987) (4)
- Effects of perindopril in hypertensive patients with or without type 2 diabetes mellitus, and with altered insulin sensitivity (2007) (4)
- Erratum: The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation (2016) (4)
- Effects of intensive blood glucose control on vascular outcomes in patients with type 2 diabetes (2009) (4)
- Contribution of Angiotensin I Converting Enzyme I/D polymorphism to the development and progression of diabetic nephropathy in type 1 diabetes: a 6-year follow-up observational study (1999) (4)
- Sex hormone levels are not associated with progression of renal disease in male patients with T2DM. (2017) (4)
- Genetics and Diabetic Nephropathy (2000) (4)
- Microalbuminuria and ACE inhibition in non-hypertensive diabetics. (1990) (4)
- Association of ACACB gene polymorphism (rs2268388, G > A) with type 2 diabetes and end stage renal disease in Pakistani Punjabi population (2017) (4)
- Comment on: Zhu et al. Fasting Plasma Glucose at 24–28 Weeks to Screen for Gestational Diabetes Mellitus: New Evidence From China. Diabetes Care 2013;36:2038–2040 (2013) (4)
- T-cadherin gene variants are associated with nephropathy in subjects with type 1 diabetes (2017) (3)
- Erratum: Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia (2009) (3)
- Microalbuminuria, glomerular filtration rate, and dietary fat and protein intakes in type 1 diabetes. (1999) (3)
- Évaluation des effets cardiovasculaires du liraglutide : Conception et données de base de l’étude Liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER®) (2015) (3)
- [Treatment of hypertensive type 2 diabetes patients with microalbuminuria]. (2002) (3)
- Author response for "Response of 1,5‐anhydroglucitol to intensive glucose‐ and blood‐pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial" (2019) (3)
- Comparison of a new versus standard removable offloading device in patients with neuropathic diabetic foot ulcers: a French national, multicentre, open-label randomized, controlled trial (2020) (3)
- [Nephropathy in non-insulin-dependent diabetics]. (1996) (3)
- La microalbuminurie chez les diabétiques. I--Définition, intérêt et physiopathologie. (1987) (3)
- Relationship between cardiac microvascular dysfunction measured with 82 Rubidium-PET and albuminuria in patients with diabetes mellitus (2018) (3)
- Beta-cell cytoadherent lymphocytes in some subjects at risk for type 1 (insulin-dependent) diabetes: progression to diabetes within 2 years. (1990) (3)
- La microalbuminurie chez les diabétiques. II: Aspects méthodologiques et perspectives thérapeutiques (1987) (3)
- Beginning insulin in people with type 2 diabetes mellitus in real life practice-1-year results of the 4-year CREDIT Study (2010) (3)
- Prevention of vascular outcomes in type 2 diabetes: benefits of intensive blood pressure and blood glucose control with Preterax and Diamicron MR, Issue III (2008) (3)
- A genetic variant in HK 1 is associated with pro-anemic state and HbA 1 c but not other glycemic control related traits Running head : HK 1 variant , glycated hemoglobin and anemia (2009) (3)
- Reducing cardiovascular risk in diabetes. (2007) (3)
- Cardiovascular (CV) Risk Evaluation in People with Type 2 Diabetes (T2D) on Insulin Therapy (CREDIT) Study-CV Disease and CV Risk at Baseline (2009) (3)
- [Increase of activity of angiotensin-converting enzyme in insulin-dependent diabetic patients with permanent microalbuminuria]. (1992) (3)
- Association Between the ACE Insertion/Deletion Polymorphism and Risk of Lower-Limb Amputation in Patients With Long-Standing Type 1 Diabetes. (2021) (3)
- Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial (2021) (3)
- Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trials (2017) (3)
- Serum lipids and urinary albumin excretion in non insulin-dependent diabetics (1992) (2)
- Polygenic Risk Testing at the Time of Diagnosis of Diabetes Could Help Prevent Its Micro- and Macrovascular Complications (2018) (2)
- Cardiovascular Risk Evaluation in People with Type 2 Diabetes (T2D) on Insulin Therapy (CREDIT) Study: Patterns of Initial Prescription of Insulin and Associated Changes in Oral Glucose-Lowering Drug (OGLD) Therapy (2009) (2)
- Dairy consumption and the incidence of hyperglycaemia and the metabolic syndrome : results from a French prospective study (2011) (2)
- The canosinase gene (CNDP1) is not a protection factor of diabetic nephropathy in type 1 diabetics (2006) (2)
- ACE I/D Polymorphism, Plasma ACE Levels, and Long-term Kidney Outcomes or All-Cause Death in Patients With Type 1 Diabetes (2021) (2)
- Risk factors for symptomatic hypoglycaemia in people with type 2 diabetes mellitus initiated on insulin therapy: evidence from the CREDIT study (2010) (2)
- Insulinosensibilité, pression artérielle et maladies cardiovasculaires (2001) (2)
- Nephropathy in type 1 diabetes. (2002) (2)
- Polygenic risk scores predict diabetic complications and their response to therapy (2019) (2)
- [Cerebral tomodensitometric anomalies in anorexia nervosa]. (1981) (2)
- Relationship between renal capacity to reabsorb glucose and renal status in patients with diabetes. (2020) (2)
- Association of Diuretics Use and Amputations in Patients with Type 2 Diabetes—A Hypothesis Driven from Canvas Warning? (2018) (2)
- Insulin Initiation in People with Type 2 Diabetes Mellitus (T2DM) in Real Life Practice-1-Year (yr) Results of the 4-yr CREDIT Study (2010) (2)
- Ef fi cacy and Safety of Sitagliptin Versus Glipizide in PatientsWith Type 2 Diabetes andModerate-to-Severe Chronic Renal Insuf fi ciency (2012) (2)
- The Concept of Incipient Diabetic Nephropathy and Effect of Early Antihypertensive Intervention (2000) (2)
- [Paracetamol and leukocytoclastic vasculitis: apropos of a case]. (1995) (2)
- Insulinorésistance, hypertension artérielle et prévention cardiovasculaire (2008) (2)
- Obstetric adiposity in the Mediterranean region (2013) (2)
- [Microalbuminuria and left ventricular hypertrophy in essential arterial hypertension. A study in non-diabetic patients]. (1992) (2)
- Association of impaired renal function with venous thrombosis: A genetic risk score approach. (2017) (2)
- [A common mutation C677T in the 5,10-methyltetrahydrofolate reductase gene is associated to idiopathic deep venous thrombosis]. (2003) (2)
- Sulfamides hypoglycémiants : les diurétiques de la diabétologie (2017) (2)
- [Hypertension and diabetes]. (2000) (2)
- [Differences in glycemic balance (but not weight) correlate positively with changes in absolute cardiovascular risk in diabetic patients]. (2000) (2)
- THE FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE HAS A GREATER EFFECT ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND ALBUMINURIA (2009) (2)
- Microalbuminuria a marker for peripheral vascular disease in type 1 insulin dependent diabetic patients (1988) (2)
- 22nd European Congress on Obesity (ECO2015), Prague, Czech Republic, May 6-9, 2015: Abstracts (2015) (2)
- Le traitement de l'hypertension artérielle chez les diabétiques (1986) (1)
- [Management of diabetic nephropathy before and during pregnancy]. (2001) (1)
- Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all‐cause mortality in individuals with type 2 diabetes in the ADVANCE trial (2020) (1)
- [Normal and abnormal daily variability of urinary excretion of albumin]. (2000) (1)
- Differential prognostic burden of cardiovascular disease and lower-limb amputation on the risk of all-cause death in people with long-standing type 1 diabetes (2022) (1)
- Superiority of angiotensin I converting enzyme inhibition over conventional antihypertensive treatment to reduce microalbuminuria of normotensive type I diabetic patients (1992) (1)
- [STUDIES ON LEBER'S OPTIC ATROPHY]. (1963) (1)
- The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels, and reduces type 2 diabetes risk in a prospective general French population: the D.E.S.I.R. Study (2008) (1)
- Associations of microvascular complications with all‐cause death in patients with diabetes and COVID‐19: The CORONADO, ABCD COVID‐19 UK national audit and AMERICADO study groups (2022) (1)
- ACE inhibitors and diabetics with albuminuria. The DIABHYCAR Study Group. (1995) (1)
- [Prevalence of antinuclear antibodies in hypertensive diabetics treated with acebutolol]. (1984) (1)
- [Effect of pre-existing hypertension on the prevalence and incidence of microalbuminuria in non insulin-dependent diabetic patients]. (1991) (1)
- Genetics of diabetic nephropathy (2000) (1)
- Contribution of heterozygous PCSK1 variants to obesity and implications for precision medicine: a case-control study. (2023) (1)
- No prognostic role of a GWAS-derived genetic risk score in renal outcomes for patients from French cohorts with type 1 and type 2 diabetes. (2018) (1)
- Dairy consumption is associated with lower plasma dihydroceramides in women from the D.E.S.I.R. cohort. (2020) (1)
- A KQ121 variant in the PC-1 gene and diabetic nephropathy: discrepant results between North and South Europe. (2002) (1)
- [Treatment of arterial hypertension in diabetics. Contribution of converting enzyme inhibitors]. (1985) (1)
- Plasma total adiponectin and changes in renal function in a cohort from the community: the prospective Data from an Epidemiological Study on the Insulin Resistance Syndrome study. (2020) (1)
- Short-term effect of severe hypoglycaemia on glycaemic control in the Diabetes Control and Complications Trial. (2017) (1)
- Early Antihypertensive Intervention in Diabetic Patients with Incipient Nephropathy (2001) (1)
- Effects of Converting Enzyme Inhibition with Enalapril Administered to Hypertensive Insulin-dependent Diabetics (idd) (1985) (1)
- [Pyomyositis of the lateral vastus muscle in a diabetic female patient]. (1993) (1)
- Efficacy of a fixed combination metformin/glibenclamide in metformin failure type 2 diabetes patients (2000) (1)
- Response to Comment on Balkau et al. Factors Associated With Weight Gain in People With Type 2 Diabetes Starting on Insulin. Diabetes Care 2014;37:2108–2113 (2014) (1)
- [Isolation and differeniation of adenovirus type 8 in epidemic keratoconjunctivitis in Leipzig]. (1967) (1)
- Calcium Antagonists and Glucose Tolerance: Dissociated Effects of Nicardipine on Vascular Tone and Insulin Secretion (1985) (1)
- ACE inhibitors and diabetics with albuminuria (1995) (1)
- The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19) (2022) (1)
- [Microalbuminuria and non-insulin-dependent diabetes: practical interpretation and therapeutic consequences]. (1995) (1)
- Genome-wide physical activity interactions in adiposity (2017) (1)
- YIA 03-01 VALIDATION OF GENETIC DETERMINANTS OF UNMET NEEDS IN THE TREATMENT OF KIDNEY DISEASE IN TYPE-2 DIABETES. (2016) (1)
- 629-P: Bedside Blind Bone Biopsy for Diagnosis of Diabetic Foot Osteitis Allows Similar Healing Rate as Conventional Bone Biopsy (2019) (1)
- Short-Term Changes in Serum Potassium and the Risk of Subsequent Vascular Events and Mortality (2022) (1)
- [What allows a type 1 diabetic to be well controlled]. (2002) (1)
- OS 05-01 PROX1 GENE CC GENOTYPE AS A MAJOR DETERMINANT OF EARLY ONSET OF T2D AND CARDIOVASCULAR COMPLICATIONS IN SLAVIC SUBJECTS FROM ADVANCE STUDY (2016) (1)
- Plasma PCSK9 and cardiovascular events in type 2 diabetes. (2017) (1)
- Minimal contribution of nausea or vomiting to superior semaglutide-mediated weight loss vs. exenatide and dulaglutide in type 2 diabetes (2019) (1)
- [Laser immunonephelometry for the determination of the urinary excretion of albumin]. (1986) (1)
- [Comparison of 3 methods of measurement of blood pressure in insulin-dependent diabetic patients with or without incipient diabetic nephropathy]. (1992) (1)
- [Insulin sensitivity, blood pressure and cardiovascular diseases]. (2001) (1)
- [Calcium antagonists and glycoregulation: dissociated effects of nicardipine on vascular tonus and insulin secretion]. (1985) (1)
- Recent advance in the treatment of diabetic nephropathy: angiotensin I converting enzyme (ACE) inhibitors. (1991) (1)
- [Spontaneous rupture of the splenic artery in an alcoholic diabetic hypertensive woman]. (1992) (1)
- [Early detection of microalbuminuria by a new technic rapid, sensitive and automatable: nephelometry]. (1986) (1)
- [Choice of first line treatment for arterial hypertension: should one avoid dihydropyridines in diabetic patients?]. (1998) (1)
- [Dissociation of hypotensive and renal hemodynamic effects of an angiotensin converting enzyme inhibitor in insulin-dependent diabetic patients with incipient nephropathy]. (1991) (1)
- [Vascular wall and diabetes mellitus: what complications and why?]. (1997) (1)
- [Contribution of arterial hypertension to vascular risk in diabetic patients]. (1999) (1)
- Effects of glucose and blood pressure reduction on subclinical cardiac damage: Results from ADVANCE. (2022) (1)
- The CETP TaqI B Polymorphism is Associated with the Risk of Sudden Death in Type 2 Diabetic Patients (2007) (1)
- Pathogénie et traitement de la glomérulopathie diabétique (1995) (1)
- Société Francophone du Diabète (SFD): Communications OralesCO-51 - Un programme automatisé d’accompagnement nutritionnel améliore les habitudes alimentaires et l’équilibre glycémique de patients diabétiques de type 2 avec obésité abdominale : essai randomisé ANODE (2017) (1)
- Place de la photographie du fond d'oeil pour le dépistage de la rétinopathie diabétique (2008) (1)
- Société Francophone du Diabète (SFD): Communications OralesCO-93 - Étude LEADER : liraglutide et évolution de la fonction rénale dans le diabète de type 2 (2017) (1)
- L’AMP-activated protein kinase : de la régulation énergétique au syndrome métabolique (2006) (1)
- La recherche de la microalbuminurie chez les diabétiques (1986) (1)
- Décès, insuffisance rénale terminale et déclin de la fonction rénale chez sujets avec néphropathie diabétique : risques équivalents entre diabète de type 1 et de type 2 (2015) (1)
- Évaluation d'une seringue à insuline avec système de sécurité (2003) (1)
- RUPTURE SPONTANEE DE L'ARTERE SPLENIQUE CHEZ UNE FEMME ETHYLIQUE, DIABETIQUE, HYPERTENDUE (1992) (1)
- Génétique de la néphropathie diabétique (2000) (1)
- Dépistage de la rétinopathie diabétique par des photographies du fond d'œil : Évaluation d'un programme en médecine libérale (étude DODIA) (2005) (1)
- P1163 Première année de suivi de l’étude CREDIT-France : Modalités, efficacité et tolérance de l’insulinothérapie en vie réelle (2013) (1)
- O37 L’insuline dégludec comparée à l’insuline glargine diminue le nombre d’épisodes d’hypoglycémie nocturne: résultats à 1 an des essais randomisés en basal-bolus chez des diabétiques de type 1 (DT1) et de type 2 (DT2) (2012) (1)
- [Urinary excretion of albumin and lipid abnormalities in hypertensive insulin-dependent diabetics]. (1990) (0)
- Diabetes Efficacy of Indapamide SR Compared With Enalapril in Elderly Hypertensive Patients With Type 2 Diabetes (2006) (0)
- A28Loss Of Nocturnal Blood Pressure Decrease In Non-Insulin Dependent Diabetic Subjects With Micro-Albuminuria. (1995) (0)
- Erratum. Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control. Diabetes 2019;68:441—456 (2020) (0)
- Genome-wide physical activity interactions in adiposity A meta-analysis of 200,452 adults Genome-wide physical activity interactions in adiposity ― A meta-analysis of 200,452 adults (2017) (0)
- Common variants near BDNF and SH2B1 show nominal evidence of association with snacking behavior in European populations (2013) (0)
- 421-P: Differential Prognostic Burden of Lower-Limb Amputation and Cardiovascular Disease on the Risk of All-Cause Death in People with Type 1 Diabetes (2022) (0)
- Supplementary material : No prognostic role of a GWAS-derived genetic risk score in renal outcomes for patients from French cohorts with type 1 and type 2 diabetes (2018) (0)
- Modalités d’instauration d’un traitement par association fixe Degludec-Liraglutide en situation de vie réelle : étude multicentrique française (2018) (0)
- O33 Un criblage du génome entier identifie plusieurs polymorphismes nucléotidiques impliqués dans la régulation du taux de biomarqueurs circulants reliés aux complications du diabète (2014) (0)
- A27 - Loss of nocturnal blood pressure decrease in essential hypertensive subjects with microalbuminuria (1995) (0)
- [Microalbuminuria in diabetics. I--Definition, significance and physiopathology]. (1987) (0)
- Immunonéphélémétrie-laser pour le dosage de l'excrétion urinaire d'albumine. (1986) (0)
- [Prevention of cardiovascular risk in diabetes]. (2007) (0)
- [New insulins]. (1982) (0)
- Genetic studies of diabetic nephropathy in three European populations (EURAGEDIC consortium): analyses of 14 candidate genes on chromosome 3q (2005) (0)
- D70 Effect of trandolapril on urinary albumin excretion and circadian blood pressure variations in diabetic non-dipper hypertensive patients (1997) (0)
- Blood Coagulation, Fibrinolysis and Cellular Haemostasis Association of vitronectin and plasminogen activator inhibitor-1 levels with the risk of metabolic syndrome and type 2 diabetes mellitus Results from the D.E.S.I.R. prospective cohort (2017) (0)
- Sattar, N. (2018). Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE (2018) (0)
- [Converting enzyme inhibitors in diabetes]. (1992) (0)
- O85 La concentration sanguine d’ADN bactérien prédit la survenue du diabète en population générale (2011) (0)
- 70 17q21.31 CNV DOSE DEPENDENT EFFECT ON THE PREVALENCE OF HYPERTENSION AND DYSLIPIDEMIA COMORBIDITY (2012) (0)
- 29. THE CONCEPT OF INCIPIENT D1ABETIC NEPHROPATHY AND EFFECT OF EARLY ANTIHVPERTENSIVE INTERVENTION (1994) (0)
- La stato-hpatite non alcoolique (NASH) : une entit clinique en expansion (2004) (0)
- PDB79 DO PEOPLE BEGINNING BASAL INSULIN HAVE A DISTINCT CLINICAL PROFILE COMPARED WITH THE OVERALL POPULATION IN THE CREDIT STUDY (2009) (0)
- Among Closely Related Bacterioplankton Resource Partitioning and Sympatric Differentiation (2008) (0)
- YIA 03-01 VALIDATION OF GENETIC DETERMINANTS OF UNMET NEEDS IN THE TREATMENT OF KIDNEY DISEASE IN TYPE-2 DIABETES. (2016) (0)
- in people with type-2 diabetes : a prospective cohort study from ADVANCE Comparison of waist-to-hip ratio and other obesity indices as predictors of cardiovascular disease risk (2011) (0)
- 1017-P: Association between Death at Day 28 and Components of Microvascular Disease of with Diabetes Hospitalized for Coronavirus Disease-2019 (COVID-19): The CORONADO Study (2021) (0)
- Genetic polymorphism of transforming growth factor-β1 and microvascular complications in type 1 diabetes (2000) (0)
- Comparison of three methods of blood pressure measurement in insulin-dependent diabetic subjects with or without incipient nephropathy (1992) (0)
- [Reflexion of French experts on the key points of the symposium]. (2002) (0)
- Increase in serum angiotensin I converting enzyme activity after oral glucose loading (1992) (0)
- Reduction of a Permanent Microalbuminuria in Uncomplicated Essential Hypertensives by an Effective Antihypertensive Treatment (1986) (0)
- 431-P: Diabetic Retinopathy and Risk of Lower-Extremity Artery Disease in Type 2 Diabetes (2019) (0)
- Subject Index Vol. 1, 2008 (2008) (0)
- PREDICTIVE VALUE OF BLOOD BACTERIAL DNA ON THE ONSET OF TYPE 2 DIABETES FROM GENERAL POPULATION: 7E.11 (2011) (0)
- D87: Predictive factors of abnormal urinary albumin excretion in diabetic hypertensive patients (1997) (0)
- O59 La consommation de lipides et le polymorphisme L162V de PPAR α modulent la glycémie et le risque de diabète dans l’étude prospective DESIR (2012) (0)
- Dépistage et prise en charge précoce : de la néphropathie diabétique (2005) (0)
- Leukocyte telomere length, allelic variations in related genes and risk of coronary heart disease in people with long-standing type 1 diabetes (2022) (0)
- Semaglutide Provides Superior Body Weight Reduction Across Sustain 1–5 Clinical Trials (2018) (0)
- PDB78 DIFFERENCES IN THE CHARACTERISTICS OF PEOPLE WITH TYPE 2 DIABETES STARTING INSULIN IN THE NORTH, SOUTH AND EAST OF EUROPE: DATA FROM THE CREDIT STUDY (2009) (0)
- [Relations between arterial hypertension and diabetic nephropathy]. (1987) (0)
- EURAGEDIC study: identification of new candidate genes for diabetic nephropathy (2007) (0)
- Initiation of the Fixed Combination IDegLira in Patients with Type 2 Diabetes on Prior Injectable Therapy: Insights from the EASY French Real-World Study (2022) (0)
- P90 - La chirurgie de by-pass gastrique (Roux-en-Y) pour quels patients diabétiques ? (2008) (0)
- [Can coronary risks be further reduced?]. (2004) (0)
- Central obesity markers, but not BMI, are associated with cardiovascular risk in type 2 diabetic patients: results from the ADVANCE study (2009) (0)
- [Reduction of urinary kallikrein in hypertensive diabetics]. (1986) (0)
- CO83 - Identification de nouveaux gènes de susceptibilité au diabète de type 2 par une étude d’association génome entier par puces à ADN dans la population française (2008) (0)
- [Is it necessary to systematically treat diabetics with ACE inhibitors?]. (2001) (0)
- Quelle HbA1c viser (1998) (0)
- Reduction in the nocturnal arterial pressure fall in type II diabetic subjects with microalbuminuria (1997) (0)
- [Central nervous sytem control of pancreatic hormones by neural pathways]. (1981) (0)
- Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study) (2004) (0)
- Additional file 1: of The evaluation of off-loading using a new removable oRTHOsis in DIABetic foot (ORTHODIAB) randomized controlled trial: study design and rationale (2016) (0)
- [Metabolic mechanisms of renal fibrosis: diabetes]. (1999) (0)
- Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control (2021) (0)
- Modifications of urinary kallikrein in diabetics (1984) (0)
- EFFICACY OF INDAPAMIDE SR IN HYPERTENSIVE, TYPE 2 DIABETICS: 24H ABPM (2004) (0)
- [Tropical ophthalmology in Central Burma]. (1967) (0)
- Corrigendum to “A composite risk assessment model to screen for gestational diabetes mellitus among Mediterranean women” [Int J Gynecol Obstet 120 (2013) 240–244] (2013) (0)
- 406-P: Efficacy and Safety of Finerenone in Patients with CKD and T2D by GLP-1RA Treatment (2021) (0)
- The Influence of Exercise on Vascular Complications and Mortality Ii Patients with Type 2 Diabetes Mellitus (2012) (0)
- [Increase of angiotensin converting enzyme activity during oral load of glucose]. (1992) (0)
- ["Diabetic rosettes": a cellular immunity marker in subjects at risk for type I diabetes]. (1990) (0)
- [Type 2 diabetes: new therapeutic perspectives]. (1998) (0)
- Acknowledgement to Revierwers (2008) (0)
- [Utility of nursing consultations after hospitalization for patients on insulin]. (2003) (0)
- OS 05-01 PROX1 GENE CC GENOTYPE AS A MAJOR DETERMINANT OF EARLY ONSET OF T2D AND CARDIOVASCULAR COMPLICATIONS IN SLAVIC SUBJECTS FROM ADVANCE STUDY. (2016) (0)
- Front & Back Matter (2012) (0)
- Vascular and insulinotropic effects of YC 170, a calcium agonist, on isolated perfused rat pancreas. (1990) (0)
- Microalbuminuria in current practice (1987) (0)
- 550-P: Age at Diabetes Onset and Risk for Diabetic Kidney Disease (2019) (0)
- 0281: A novel device for measuring arterial stiffness using the finger-toe pulse wave velocity: validation study of the pOpmètre® (2014) (0)
- 323-OR: Associations of Leukocyte Telomere Length and Related Allelic Variations with the Risk of Coronary Events in People with Long-Standing Type 1 Diabetes (2022) (0)
- [Diabetes complications. Strict blood glucose controls and beyond]. (2007) (0)
- 647-P: Efficacy and Safety of GLP-1RAs with or without Baseline SGLT2i: Post-hoc Analysis of the SUSTAIN 10 Trial (2021) (0)
- [Importance and significance of guided virological studies in abacterial infectious diseases of the eye. II. Studies of the infectious abacterial (kerato-) conjunctivitis from the university ophthalmological clinics of Leipzig]. (1969) (0)
- O97 Des variants du gène MTNR1B du récepteur 2 à la mélatonine augmentent la glycémie et le risque de DT2 : un lien entre le rythme circadien et le diabète ? (2009) (0)
- Contents Vol. 1, 2008 (2008) (0)
- [New trails in diabetology]. (2003) (0)
- P175 L’insuline Détémir améliore l’équilibre glycémique et diminue le risque d’hypoglycémies sans variation pondérale : données à 52 semaines de l’étude Predictive TM sur une cohorte de patients français diabétiques de type 1 et 2 (2009) (0)
- [How do we detect and maintain surveillance on diabetic nephropathies at onset?]. (1984) (0)
- Plasma Adrenomedullin, Allelic Variations in the ADM Gene, and Risk for Lower-Limb Amputation in People With Type 2 Diabetes. (2022) (0)
- Routine blood pressure lowering and kidney disease in type 2 diabetes (2009) (0)
- Protection against cardiovascular and renal disease in type 2 diabetes: ADVANCEs in the control of blood pressure using Preterax and Diamicron MR. (2010) (0)
- Arterial stiffness measurement in obese patients with a new device: pOpmetre® (2013) (0)
- Patients are more likely to reach A1Ctarget when liraglutide is added to an SU than adding rosiglitazone or placebo (2013) (0)
- Efficacy and Safety of Finerenone in Patients with CKD and T2D by GLP-1RA Treatment (2021) (0)
- P348 - Le polymorphisme K121Q d’ENPP1 est associé à l’obésité sévère et au diabète de type 2 familial, et augmente l’incidence de l’hyperglycémie dans l’étude prospective DÉSIR (2008) (0)
- [Dyslipoproteinemia and diabetic nephropathy]. (1991) (0)
- Abstract 13812: The Influence of Exercise on Vascular Complications and Mortality Ii Patients with Type 2 Diabetes Mellitus (2012) (0)
- Prognostic Values of Inflammation and Oxidative Stress Biomarkers on the Risk of Peripheral Arterial Disease in Type 2 Diabetes (2018) (0)
- 1A.09: DISTINCT GENETIC ARCHITECTURE OF RENAL IMPAIRMENT COMPONENTS IN TYPE 2 DIABETES WITHIN CAUCASIAN POPULATIONS OF CELTO-GERMANIC AND SLAVIC ORIGINS (2015) (0)
- Inflammatory markers and the risk of vascular complications and mortality in type 2 diabetes mellitus (2013) (0)
- COPEPTIN IN CKD (2014) (0)
- Reduced urinary kallikrein in hypertensive diabetic patients. (1988) (0)
- 67-OR: Plasma Copeptin and Risk for Lower Extremity Amputation in People with Type 1 and Type 2 Diabetes (2019) (0)
- Méta-analyse des études SUSTAIN 1-5 : Perte de poids sous semaglutide dans le diabète de type 2 (2017) (0)
- Patterns of cardiovascular risk and disease amongst people with type 2 diabetes starting insulin: baseline characteristics in the CREDIT study (2009) (0)
- O71 Diabète gestationnel dans le bassin méditerranéen (2012) (0)
- O53 La voie des kynurénines est dérégulée dans l’obésité (2015) (0)
- P1132 Efficacité et tolérance du lixisénatide en une injection quotidienne après échappement à l’insuline basale ± metformine au cours du diabète de type 2 : étude GetGoal-L (2013) (0)
- O37 L’activation pharmacologique du récepteur B1 des kinines permet de vaincre la résistance aux traitements cardioprotecteurs induit par le diabète dans l’ischémie myocardique (2013) (0)
- O35 Polymorphismes du gène de la t-cadhérine (CDH13), adiponectine circulante et risque de diabète de type 2 (2014) (0)
- CO-17: Polymorphismes du gène de la t-cadhérine (CDH13), adiponectinémie et indice de stéatose hépatique dans DESIR (2016) (0)
- O98 Diminution du risque de maladie coronarienne chez les diabétiques de type 2 associé à l’allèle A du variant fonctionnel -866G>A du promoteur d’Ucp2. Étude prospective Diabhycar (2008) (0)
- O52 L’activité enzymatique plasmatique de l’amylase pancréatique est associée à une diminution de l’indice de masse corporelle et protège du risque de diabète dans la cohorte D.E.S.I.R. (2015) (0)
- O56 L’exposition fœtale au diabète maternel est associée à des différences de méthylation de l’ADN génomique (analyse pan-génomique) (2012) (0)
- Bénéfice du liraglutide dans la réduction des complications podologiques des patients diabétiques de type 2 : analyses secondaires de l’étude LEADER (2018) (0)
- Prise en charge de la néphropathie diabétique avant et pendant la grossesse (2001) (0)
- Iconographies supplémentaires de l'article : Réduire l’albuminurie : est-ce un facteur indépendant de diminution du risque cardiovasculaire ? (2010) (0)
- CA-057: Intérêt de la biopsie osseuse dans la prise en charge de l'ostéite du pied diabétique : étude rétrospective monocentrique (2016) (0)
- O92 Le gène du BNP est fortement associé au risque de diabète de type 2 : analyse haplotypique de l’étude DESIR (Données Épidémiologiques sur le Syndrome d’Insulino-Résistance) (2008) (0)
- ACE I/D polymorphism predicts end stage renal disease and or mortality in type I diabetic patients except for those with already advanced nephropathy: the follow up of the Genesis/Genediab Studies (2007) (0)
- Prévention des complications rénales dans l'HTA: l'étude NESTOR (2003) (0)
- CO82 - Le génotype TT du polymorphisme C-58T du récepteur de type 2 à la bradykinine (BDKRB2) est associé à un risque augmenté de diabète de type 2 (DT2) dans la population générale : l’étude DESIR (2008) (0)
- Diabète du sujet âgé (1984) (0)
- Inflammatory Biomarker Levels and The Risk of Vascular Complications and Mortality in Type 2 Diabetes Mellitus (2013) (0)
- Abstract 3459: Human Atrial Natriuretic Peptide (ANP) Gene Is Associated With Metabolic Syndrome In The French Population (2007) (0)
- Anomalies lipidiques et autres facteurs de risque d'accident vasculaire cérébral chez le diabétique (1990) (0)
- Durabilité de l’efficacité du contrôle glycémique sous liraglutide dans l’étude LEADER (2018) (0)
- P205 Polymorphismes de STAMP2 et syndrome métabolique : l’étude D.E.S.I.R (2010) (0)
- Penser au phéochromocytome devant tout incidentalome surrénalien (2016) (0)
- O91 Gène de l’ANP et facteurs de risques cardiométaboliques dans la population française (2008) (0)
- O99 La mutation fréquente non synonyme P446L de GCK-RP module inversement la glycémie et les triglycérides, et réduit le risque de diabète de type 2 dans la population générale française D.E.S.I.R (2008) (0)
- CONTRIBUTION DE L'HYPERTENSION ARTÉRIELLE AU RISQUE VASCULAIRE DU DIABÉTIQUE (1999) (0)
- Modalités de remplacement dâune association libre dâinsuline basale et agoniste du GLP-1R par la combinaison fixe Degludec-Liraglutide en situation de vie réelle : étude multicentrique française. (2018) (0)
- Évaluation d’un nouveau dispositif amovible innovant de décharge plantaire dans la cicatrisation des ulcères plantaires du pied chez les patients diabétiques : ORTHODIAB – Étude randomisée multicentrique nationale (2017) (0)
- La découverte d'une néoplasie lors d'une thrombose veineuse profonde ne modifie pas le pronostic vital chez le sujet âgé (1995) (0)
- Décès du Docteur Jean Tichet (1942–2022) (2023) (0)
- Erratum (1996) (0)
- Acidose lactique et traitement par les biguanides (1984) (0)
- O67 Polymorphismes du gène de la t-cadhérine (CDH13) et néphropathie dans le diabète de type 1 (2015) (0)
- O67 Polymorphismes du gène de la t-cadhérine (CDH13) et néphropathie dans le diabète de type 1 (2015) (0)
- Insuffisance coronaire chez le diabétique : Approche de l'exploration, en particulier du fait de l'ischémie silencieuse (1997) (0)
- Protection cardio-vasculaire et rénale : la place des IEC (2004) (0)
- P253 Le système kallicréine-kinine ne joue pas de rôle majeur dans la physiopathologie de l’insulino-résistance (2010) (0)
- Effet de l'hypertension artérielle essentielle sur l'excrétion urinaire d'albumine des diabétiques non insulino-dépendants (1990) (0)
- Évaluer pour décider. Quand demander et comment interpréter une microalbuminurie (1998) (0)
- Relation entre enzyme de conversion et microangiopathie chez des diabétiques insulino-dépendants : analyse génotypique et phénotypique (1992) (0)
- Efficacité et tolérance d'IDegLira en cas d'insuffisance rénale légère à modérée : analyses des études de phase III (2018) (0)
- Lésions des petites fibres du système nerveux autonome et gradation du risque podologique chez les patients diabétiques (2019) (0)
- La mutation C677T du gène de la méthylènetétrahydrofolate réductase est associée aux thromboses veineuses inexpliquées (1999) (0)
- Étude LEADER - liraglutide et événements cardiovasculaires : analyse complémentaire chez les sujets âgés ≥ 75 ans (2018) (0)
- Prise en charge de la néphropathie diabétique (2002) (0)
- [IV. Management of diabetic neuropathy]. (2002) (0)
- CA-013: Réduction des hypoglycémies nocturnes avec l'insuline basale peglispro (BIL) comparée à l'insuline glargine (GL) : analyses poolées de 5 études contrôlées randomisées (2016) (0)
- CO18 - Rôle du système kallicréine-kinines dans les complications rénales et vasculaires du diabète – Étude expérimentale chez la souris (2008) (0)
- Microalbuminurie et diabète non insulino-dependant : interprétation pratique et conséquences thérapeutiques (1995) (0)
- Carl Erik Mogensen et le concept de néphropathie diabétique débutante (2020) (0)
- O32 La variabilité du nombre de copies de gènes est associée à l’hypertension dans le diabète de type 2 (2014) (0)
- Symposium - Peut-on réduire davantage le risque coronaire ? (2008) (0)
- Les insulines: un domaine en pleine mutation (1983) (0)
- PO32 Concentrations sériques de stéroïdes sexuels, gène de l’aromatase (CYP19A1) et risques cardiovasculaire et rénal chez des sujets diabétiques de type 2 (2013) (0)
- O31 Deux scores de risque génétique sont fortement associés aux variations de glycémie à jeun et à l’incidence d’hyperglycémie et de diabète de type 2 dans l’étude prospective D.E.S.I.R (2014) (0)
- Modifications des lipides sanguins et tabac chez 160 jeunes diabétiques insulino-dépendants (1990) (0)
- Utilisation des fibrates en prévention primaire chez les diabétiques de type 2 à haut risque cardiovasculaire (2014) (0)
- 263 Variants génétiques du transporteur de glucose GLUT 1 et sévérité de la rétinopathie chez le sujet diabétique de type 2 (2005) (0)
- Abondance de la glycosurie pendant l’hyperglycémie et risque de néphropathie diabétique à long terme dans le diabète de type 1 (2017) (0)
- Response rate in second-line therapy of a new fixed combination metformin/glibenclamide product (2000) (0)
- L’UKPDS 30 ans après : le livret de caisse d’épargne des diabétologues: UKPDS 30-year later: a saving book for diabetologists (2009) (0)
- O31 Apports sodés, gène du récepteur de clairance des peptides natriurétiques (NPR3) et complications cardiovasculaires chez des sujets diabétiques de type 2 (2013) (0)
- P116 Les gènes des peptides natriurétiques sont fortement associés à l’hyperglycémie dans la population française : étude DESIR (2009) (0)
- P10 Syndrome d’insulino-résistance et produits laitiers : l’étude prospective D.E.S.I.R (2010) (0)
- Comment dépister et surveiller la néphropathie diabétique débutante (1984) (0)
- CO-23: Comparaison des IEC et des ARA2 dans une population de 40 625 patients à haut risque cardiovasculaire : données de la cohorte REACH (2016) (0)
- Des taux plus faibles d’hypoglycémies avec insuline degludec / liraglutide (IDegLira) versus insuline GlargineU100 (IGlar U100) chez les diabétiques de type 2 quels que soient l’horaire d’administration ou le mode de définition des hypoglycémies (2017) (0)
- O62 Association d’un variant génétique de l’acétyl-CoA carboxylase beta avec le syndrome métabolique et le diabète de type 2 dans la cohorte DESIR (2013) (0)
- PO34 Une méta-analyse concernant la durée et l’impact des épisodes d’hypoglycémie avec l’insuline dégludec et l’insuline glargine (2014) (0)
- O55 Gènes communs à plusieurs complications du Diabète de Type 2 (2012) (0)
- [Detection of subjects at risk of type 1 diabetes. GOFEDI. Groupe Ouest-France pour l'Etude du Diabète Insulino-dépendant]. (1993) (0)
- Apport de la mesure ambulatoire de la pression artérielle dans la néphropathie diabétique débutante (1992) (0)
- P322 Premiers résultats de l’observatoire L&Vous: observatoire national de l’utilisation, en vie réelle, de l’insuline basale par les patients diabétiques de type 2 (2015) (0)
- Comment je prends en charge les œdèmes associés à la prise de glitazones (2007) (0)
- 39 Influence of pre-existing hypertension on the prevalence of elevated urinary albumin excretion in non-insulin-dependent diabetes (1991) (0)
- Le rationnel physiopathologique des risques vasculaires chez les diabétiques (2009) (0)
- Dépistage des sujets à risque de diabète de type 1 (1993) (0)
- Durabilité de l'efficacité du contrôle glycémique sous liraglutide dans l'étude LEADER (2018) (0)
- O68 Taux plasmatiques de 8-Hydroxy-2’-desoxyguanosine et risque de complications rénales chez les patients diabétiques de type 1 (2015) (0)
- Évaluation d'un nouveau rétinographe non mydriatique pour le dépistage de la rétinopathie diabétique. (2008) (0)
- Cécité bilatérale révélant une apoplexie hypophysaire (2016) (0)
- Description des infarctus du myocarde et des sous-types dans l’étude LEADER (2017) (0)
- P1254 Intérêt de la mesure de la rigidité artérielle avec un nouvel appareil : pOpmètre® axelife sas - France, chez les patients obèses (2013) (0)
- O99 Impact des variations alléliques de SOD1 dans le développement et la progression de la néphropathie dans trois cohortes de diabétiques de type 1 (2009) (0)
- P263 Impact de l’obésité morbide sur la fonction rénale chez les patients diabétiques de type 2 (2014) (0)
- Sécurité du liraglutide versus placebo chez les diabétiques de type 2 insuffisants rénaux dans l’étude LEADER (2018) (0)
- Complications dégénératives du diabète non insulino-dépendant : il n'y a pas de « petit diabète » (1996) (0)
- Risque d’événements cardiovasculaires majeurs chez les diabétiques de type 2 avec ou sans antécédents d’évènements cardiovasculaires : une analyse de l’étude LEADER (2017) (0)
- Le liraglutide diminue les évènements cardiovasculaires majeurs chez les diabétiques de type 2 avec maladie rénale chronique : une analyse de l’étude LEADER (2018) (0)
- Author response for "Variability in eGFR and the risk of major clinical outcomes in diabetes: post‐hoc analysis from the ADVANCE trial" (2021) (0)
- P351 - Effet du polymorphisme 708C > T du gène de l’ANP dans la population française : l’étude DÉSIR (2008) (0)
- Quelles décisions prendre devant une microalbuminurie chez un diabétique (1996) (0)
- PO25 Concentrations sériques de stéroïdes sexuels, gène de l’aromatase et néphropathie diabétique. (2012) (0)
- Rduire lalbuminurie : est-ce un facteur indpendant de diminution du risque cardiovasculaire ? (2010) (0)
- Les inhibiteurs de la DPP4 : le rêve des diabétologues enfin réalisé ? (2008) (0)
- P1003 L’exposition fœtale au diabète maternel de type 1 et le stress oxydant (2013) (0)
- [Prospects opened by the insulin pump]. (1981) (0)
- L'insulino-résistance: un concept explicatif séduisant... des conséquences diagnostiques et thérapeutiques pragmatiques! (1994) (0)
- Efficacité et tolérance d'IDegLira en cas d'insuffisance rénale légère à modérée : analyses des études de phase III (2018) (0)
- Hypoglycémies et prise de poids: Association entre hypoglycémie non sévère et gain de poids chez les patients atteints de diabète de type 1: Résultats du DCCT (2018) (0)
- Études SWITCH 1 et 2 : réductions du risque d’hypoglycémies quelles que soient leurs définitions avec IDeg versus IGlar (2018) (0)
- Néphropathie et H.T.A. chez le diabétique: rétrospective et perspectives (1988) (0)
- O61 Le diabète de type 2 est responsable d’anomalies chromosomiques somatiques en mosaïques qui sont pré-cancéreuses (2013) (0)
- Utilité des consultations infirmières après hospitalisation pour les patients sous insuline (2003) (0)
- 038 Les variations alléliques du gène codant pour la catalase sont associées au risque de développement et de progression de la néphropathie diabétique dans le diabète de type 1 : cohortes SURGENE et GENEDIAB (2011) (0)
- CO81 - Risque prédictif de variants génétiques associés au Diabète de Type 2 dans la cohorte prospective française DESIR (2008) (0)
- Nouvelles pistes en diabétologie (2003) (0)
- Pas d’augmentation des taux de calcitonine ni de cas de cancer à cellules C chez les patients traités par liraglutide dans l’étude LEADER (2017) (0)
- [Microalbuminuria in diabetics. II--Methodological aspects and therapeutic perspectives]. (1987) (0)
- O89 La consommation de lipides et les polymorphismes du locus PPARG modulent l’indice de masse corporelle et le risque de diabète de type 2 dans l’étude prospective D.E.S.I.R. (2011) (0)
- B013 Genetic polymorphisms of the lamina maturation pathway and their association with the metabolic syndrome: the desir prospective study (2009) (0)
- O39 Taux circulants d’adrénomédulline, risque coronarien et mortalité chez des sujets diabétiques de type 2 (2014) (0)
- Hypoglycémies sévères, événements cardiovasculaires majeurs et décès : résultats de l’étude LEADER (2017) (0)
- Concentrations plasmatiques de PCSK9 et incidence des évènements cardiovasculaires dans le diabète de type 2 (2017) (0)
- P292 Relation entre contrôle glycémique et événements cardiovasculaires (EC) dans le diabète de type 2 (DT2), durant les 4 années suivant l’instauration d’une insulinothérapie (2014) (0)
- Redox Genetic Risk Score and the Incidence of End-Stage Kidney Disease in People with Type 1 Diabetes (2022) (0)
- L'AMP-activatedproteinkinase : de larégulationénergétiqueausyndromemétabolique (2016) (0)
- Collaborateurs de la présente édition (2019) (0)
- O51 Syndrome coronarien aigu chez les diabétiques : est-ce que son pronostic s’améliore avec le temps ? (2008) (0)
- « Nouvelles pistes en diabétologie / New trails in diabetology » (2016) (0)
- 045 Fonction rénale et incidence du diabète dans la population générale (2011) (0)
- Iconographies supplémentaires de l'article : Programme L&Vous : premiers enseignements de l’Observatoire National de l’Utilisation, en vie réelle, de l’Insuline Basale par les patients diabétiques de Type 2 (2016) (0)
- P9-4 Âge de découverte du diabète de type 2 et catégorie sociale (2004) (0)
- Intérêt pronostique de la microalbuminurie chez l'hypertendu diabétique ou non diabétique (1991) (0)
- Lack of association between two endothelial constitutive nitric oxide synthase (ecNOS) gene polymorphisms and diabetic nephropathy in type 1 diabetes (1999) (0)
- Traitement des diabétiques de type 2 hypertendus ayant une microalbuminurie (2002) (0)
- Diabète et rein : avancées récentes dans la prise en charge (2004) (0)
- O100 L’architecture génétique du diabète de type 2 est modulée par le statut d’obésité (2008) (0)
- Comparaison de l'efficacité d'un inhibiteur de l'enzyme de conversion et d'un diurétique dans la prévention de la néphropathie diabétique (1992) (0)
- Peut-on réduire davantage le risque coronaire ? (2004) (0)
- O98 Des variants du promoteur du gène G6PC2 pourraient expliquer la contribution de ce locus au contrôle génétique de la glycémie (2009) (0)
- P185 - Évaluation de l’efficacité du dépistage de la rétinopathie diabétique par photographies du fond d’œil et télétransmission en milieu hospitalier (2008) (0)
- Pas d’interaction entre le bénéfice cardiovasculaire procuré par le liraglutide dans l’étude LEADER et l’existence d’une insuffisance cardiaque (2018) (0)
- P133 Polymorphisme fonctionnel de la lactase, corpulence et désordres métaboliques dans la cohorte DESIR : Interactions avec la consommation de produits laitiers. (2012) (0)
- O97 Association des isoformes de poids moléculaire moyen et bas et des polymorphismes de l’adiponectine avec la survenue d’une néphropathie chez les diabétiques de type 2 (2008) (0)
- Lifestyle Intervention Enhances HDL Function among Patients with Metabolic Syndrome Only at Normal LDL-Cholesterol Plasma Levels (2017) (0)
- Association fixe Degludec-Liraglutide en situation de vie réelle : étude multicentrique française sur les modalités dâinitiation et lâefficacité à 6 mois (2019) (0)
- [Prediction, screening and treatment of renal complications of diabetes]. (2001) (0)
- 025 L’hormone antidiurétique (ou vasopressine) est un nouveau facteur de risque du diabète, indépendant. Résultats de la cohorte D.E.S.I.R. (2012) (0)
- Le rôle du rein dans l'HTA et son traitement (1996) (0)
- [New antihypertensive therapy in diabetics]. (1987) (0)
- O45 Intérêt pronostique de l’adrénomédulline dans l’insuffisance cardiaque aiguë chez les sujets diabétiques de type 2 (2015) (0)
- O06 Le mutant perte de fonction p.R46L de PCSK9 n’est pas associé à un risque accru de diabète chez l’homme (2015) (0)
- Hypertension artérielle et diabète : Recommandations de l'ALFEDIAM (2ème partie) (1996) (0)
- Les nouveaux traitements antihypertenseurs chez les diabétiques (1987) (0)
- P7 Chez les diabétiques de type I normoalbuminuriques et normotendus, l’adiponectinémie est élevée indépendamment du sexe, de la masse grasse et de la fonction rénale (2009) (0)
- O65 L’exposition fœtale au diabète maternel est associée à un déficit de l’insulinosécrétion chez le descendant adulte de sexe féminin (2010) (0)
- O96 Implications des polymorphismes de PARP-1 dans la néphropathie diabétique des patients diabétiques de type 2 (2009) (0)
- CE QUI PERMET À UN DIABÉTIQUE DE TYPE 1 D’AVOIR SA GLYCÉMIE SOUS CONTRÔLE (2002) (0)
- Faut-il traiter systématiquement les diabétiques ... par IEC? (2001) (0)
- P135 - La métabonomique par analyse multivariée de spectres 1H-RMN Haute Résolution du plasma est peu prédictive des évènements cardiaques graves chez des diabétiques à haut risque (2008) (0)
- P38 Influence de l’origine ethnique et des polymorphismes du gène de l’adiponectine sur les facteurs de risque cardio-métabolique dans une population diabétique de type 2 aux Antilles (2009) (0)
- Diabète non insulino-dépendant (1995) (0)
- Peut-on dépister et prévenir la néphropathie diabétique? (1985) (0)
- P118 Le polymorphisme 2238T > C du gène de l’ANP est associé aux facteurs de risques cardio-métaboliques dans la population antillaise (2009) (0)
- Valeur des lipides sanguins comme marqueurs d'atteinte vasculaire chez le diabétique (1990) (0)
- Dyslipoprotéinémies et népropathie diabétique (1991) (0)
- CA-052: Déterminants des anomalies cardiaques infracliniques dans une population de diabétiques de type 1 : données échographiques et IRM (2016) (0)
- Une nouvelle stratégie thérapeutique dans le diabète de type 2 (2007) (0)
- O67 Comment évaluer la masse bêta-cellulaire résiduelle chez les patients diabétiques de type 1 ? L’Étude ImMaDiab (2013) (0)
- Prévention du risque cardio-vasculaire dans le diabète de type 2 (2000) (0)
- Étude de l’association entre la réserve de perfusion myocardique quantifiée par la TEP au 82Rubidium et la sévérité de la néphropathie diabétique (2017) (0)
- O73 Taux plasmatiques d’adrénomédulline et risque d’événements rénaux graves chez des sujets diabétiques de type 2 (2014) (0)
- P283 - Déterminants de la variation du poids dans l’étude ADVANCE (2011) (0)
- Degludec insulin compared to glargin insulin diminishes the number of nocturnal hypoglycemic episodes: results after 1 year in randomized basal-bolus trials in type 1 (DT1) and type 2 (DT2) diabetics (2012) (0)
- Antihypertensive Effect of Enalapril in Insulin-Dependent Diabetics with Mild to Moderate Uncomplicated Essential Hypertension: Evaluation of Metabolic and Renal Consequences (1986) (0)
- Choice of an Insulin Regimen at Insulin Initiation in People with Type 2 Diabetes Mellitus (T2DM)-Results from the CREDIT Epidemiological Study (2010) (0)
- 535-P: Relationship between Renal Capacities to Reabsorb Glucose and Kidney Disease in Patients with Diabetes (2019) (0)
- Angiotensin-converting enzyme genotype and progression to microalbuminuria in normoalbuminuric insulin-dependent diabetics (1999) (0)
- EURAGEDIC; European consortium for the genetics of diabetic nephropathy: strategy and first results. (2003) (0)
- Changes in Albuminuria and the Risk ofMajor (2017) (0)
- Meetings and Conferences (2008) (0)
- [Primary pulmonary arterial hypertension and auto-immune multiple endocrine disease]. (1990) (0)
- PS-C01-5: RELATIONSHIP BETWEEN MICROANGIOPATHY AND MACROANGIOPATHY IN DIABETIC PATIENTS (2023) (0)
- [Can diabetic nephropathy be detected and prevented?]. (1985) (0)
- Combination blood pressure lowering in the presence or absence of background statin and aspirin therapy: a combined analysis of PROGRESS and ADVANCE Trials (2021) (0)
- Dose titration of new metformin-glibenclamide (glyburide) fixed combination in metformin-failure type 2 diabetics (2000) (0)
- Relapsing Graves' hyperthyroidism in a male patient with central hypothyroidism after surgery of craniopharyngioma: case report (2017) (0)
- Predictive value of microalbuminuria in longstanding insulin dependent diabetes. (1993) (0)
- Vitronectin levels predict metabolic syndrome and diabetes mellitus risks through a PAI-1 dependent mechanism: a 9 year follow-up from the D.E.S.I.R. prospective cohort (2010) (0)
- [Which HbA1c to look at?]. (1998) (0)
- EURAGEDIC study: analyses of 144 candidate genes for diabetic nephropathy (2006) (0)
- Treatment of the fluids retention connected to the rosiglitazone (2006) (0)
- [Evaluation of a insulin syringe with a security system]. (2003) (0)
- [What decisions to make in view of microalbuminuria in a diabetic?]. (1996) (0)
- Renal response to increasing doses of angiotensin converting enzyme inhibitor (ACEI) in type 1 diabetes mellitus according to ACE I/D polymorphism (2001) (0)
- AUTHOR COPY ONLY Paraneoplastic hypoglycemia in a patient with a malignant solitary fibrous tumor (2014) (0)
- [Tissular toxicity of glucose and therapeutic perspectives]. (2001) (0)
- PDB77 BASELINE CHARACTERISTICS OF PATIENTS BEGINNING BASAL, BASAL PLUS SHORT-ACTING, SHORT-ACTING OR PREMIX INSULIN: DATA FROM THE CREDIT STUDY (2009) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Michel Marre?
Michel Marre is affiliated with the following schools:
